Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for De Novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas

Journal of Virology

Volumn 84, Issue 6, 2010, Pages 2946-2954

  Rauwel, Benjamin ^a,b   Mariamé, Bernard ^a,b   Martin, Hélène ^a,b   Nielsen, Ronni ^c   Allart, Sophie ^a,b   Pipy, Bernard ^d   Mandrup, Susanne ^c   Devignes, Marie Dominique ^e   Evain Brion, Danièle ^a,f,g   Fournier, Thierry ^a,f,g   Davrinche, Christian ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d IFR 31   (France)

^e LORIA   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g PremUP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTROPHOBLAST; EMBRYO DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMPLANTATION; IN VITRO STUDY; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REPORTER GENE; REPRODUCTION; TROPHOBLAST; VIRUS REPLICATION;

BASE SEQUENCE; CELL MOVEMENT; CELLS, CULTURED; CYTOMEGALOVIRUS; EMBRYO IMPLANTATION; FEMALE; GESTATIONAL AGE; HUMANS; MOLECULAR SEQUENCE DATA; PLACENTA; PPAR GAMMA; PREGNANCY; TRANSCRIPTION, GENETIC; TROPHOBLASTS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 77649120022     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01779-09     Document Type: Article

References (28)

1. AbuBakar, S., I. Boldogh, and T. Albrecht. 1990. Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem. Biophys. Res. Commun. 166:953-959.
2. Allal, C., C. Buisson-Brenac, V. Marion, C. Claudel-Renard, T. Faraut, P. Dal Monte, D. Streblow, M. Record, and J. L. Davignon. 2004. Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity. J. Virol. 78:7717-7726.
3. Barak, Y., M. C. Nelson, E. S. Ong, Y. Z. Jones, P. Ruiz-Lozano, K. R. Chien, A. Koder, and R. M. Evans. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4:585-595.
4. Collet, P., L. Domenjoud, M. D. Devignes, H. Murad, H. Schohn, and M. Dauca. 2004. The human semaphorin 6B gene is down regulated by PPARs. Genomics 83:1141-1150.
5. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator- activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649-688.
6. Fisher, S., O. Genbacev, E. Maidji, and L. Pereira. 2000. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J. Virol. 74:6808-6820.
7. Fournier, T., K. Handschuh, V. Tsatsaris, J. Guibourdenche, and D. Evain-Brion. 2008. Role of nuclear receptors and their ligands in human trophoblast invasion. J. Reprod. Immunol. 77:161-170.
8. Fournier, T., V. Tsatsaris, K. Handschuh, and D. Evain-Brion. 2007. PPARs and the placenta. Placenta 28:65-76.
9. Glass, C. K., and S. Ogawa. 2006. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat. Rev. Immunol. 6:44-55.
10. Juge-Aubry, C., A. Pernin, T. Favez, A. G. Burger, W. Wahli, C. A. Meier, and B. Desvergne. 1997. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272: 25252-25259.
11. Kornblihtt, A. R. 2005. Promoter usage and alternative splicing. Curr. Opin. Cell Biol. 17:262-268.
12. Kubota, N., Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, K. Komeda, S. Satoh, R. Nakano, C. Ishii, T. Sugiyama, K. Eto, Y. Tsubamoto, A. Okuno, K. Murakami, H. Sekihara, G. Hasegawa, M. Naito, Y. Toyoshima, S. Tanaka, K. Shiota, T. Kitamura, T. Fujita, O. Ezaki, S. Aizawa, T. Kadowaki, et al. 1999. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4:597-609.
13. Librach, C. L., S. L. Feigenbaum, K. E. Bass, T. Y. Cui, N. Verastas, Y. Sadovsky, J. P. Quigley, D. L. French, and S. J. Fisher. 1994. Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J. Biol. Chem. 269:17125-17131.
14. Marx, N., G. Sukhova, C. Murphy, P. Libby, and J. Plutzky. 1998. Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:17-23.
15. Meier, J. L., and M. F. Stinski. 1996. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39:331-342.
16. Mocarski, E., T. Shenk, and R. Pass. 2007. Cytomegaloviruses, p. 2739-2746. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott, Williams and Wilkins, Philadelphia, PA.
17. Mocarski, E. S., Jr. 2002. Virus self-improvement through inflammation: no pain, no gain. Proc. Natl. Acad. Sci. U. S. A. 99:3362-3364.
18. Narbonnet, S., and B. Mariame. 2006. The Epstein-Barr virus oncoprotein LMP1 inhibits the activity of viral or cellular promoters without inducing cytostasis. Virology 350:381-393.
19. Nielsen, R., L. Grontved, H. G. Stunnenberg, and S. Mandrup. 2006. Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery. Mol. Cell. Biol. 26:5698-5714.
20. Palmer, C. N., M. H. Hsu, H. J. Griffin, and E. F. Johnson. 1995. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:16114-16121.
21. Pavan, L., A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier. 2004. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145:4583-4591.
22. Pavan, L., A. Tarrade, A. Hermouet, C. Delouis, M. Titeux, M. Vidaud, P. Therond, D. Evain-Brion, and T. Fournier. 2003. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. Carcinogenesis 24:1325-1336.
23. Reeves, M., J. Murphy, R. Greaves, J. Fairley, A. Brehm, and J. Sinclair. 2006. Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J. Virol. 80:9998-10009.
24. Reeves, M. B., P. A. MacAry, P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
25. Rue, C. A., M. A. Jarvis, A. J. Knoche, H. L. Meyers, V. R. DeFilippis, S. G. Hansen, M. Wagner, K. Fruh, D. G. Anders, S. W. Wong, P. A. Barry, and J. A. Nelson. 2004. A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J. Virol. 78:12529-12536.
26. Tarrade, A., K. Schoonjans, L. Pavan, J. Auwerx, C. Rochette-Egly, D. Evain-Brion, and T. Fournier. 2001. PPARγ/RXRα heterodimers control human trophoblast invasion. J. Clin. Endocrinol. Metab. 86:5017-5024.
27. Yamamoto-Tabata, T., S. McDonagh, H. T. Chang, S. Fisher, and L. Pereira. 2004. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J. Virol. 78:2831-2840.
28. Zhu, H., J. P. Cong, D. Yu, W. A. Bresnahan, and T. E. Shenk. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U. S. A. 99:3932-3937.